Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Felodipine
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase I
Sponsor : Kangqi Medical Technology
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Felodipine is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Hypertension.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 14, 2022
Lead Product(s) : Felodipine
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase I
Sponsor : Kangqi Medical Technology
Deal Size : Inapplicable
Deal Type : Inapplicable